deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT02398994

A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis (STRIVE)

A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin (IVIg) Versus Standard Therapy for the Treatment of Transverse Myelitis in Adults and Children

Sponsor: Alder Hey Children's NHS Foundation Trust

Updated 9 times since 2017 Last updated: Jul 18, 2016 Started: Mar 31, 2015 Primary completion: Mar 31, 2016 Completion: Mar 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Continued effort did not successfully increase recruitment into the study.

Listed as NCT02398994, this PHASE3 trial focuses on Myelitis, Transverse and Neuromyelitis Optica and remains terminated or withdrawn. Sponsored by Alder Hey Children's NHS Foundation Trust, it has been updated 9 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshotTerminated~May 2017 – ~Apr 2018 · 11 months · monthly snapshotTerminated~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotTerminated~Oct 2021 – ~Mar 2022 · 5 months · monthly snapshotTerminated~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

9 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Mar 2022 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Oct 2021 — Mar 2022 [monthly]

    Terminated PHASE3

  5. Jan 2021 — Oct 2021 [monthly]

    Terminated PHASE3

Show 4 earlier versions
  1. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

  2. Apr 2018 — Jun 2018 [monthly]

    Terminated PHASE3

  3. May 2017 — Apr 2018 [monthly]

    Terminated PHASE3

  4. Jan 2017 — May 2017 [monthly]

    Terminated PHASE3

    First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alder Hey Children's NHS Foundation Trust
  • Barts & The London NHS Trust
  • Barts and the London School of Medicine and Dentistry
  • Birmingham Women's and Children's NHS Foundation Trust
  • Cardiff University
  • Cardiff and Vale University Health Board
  • Great Ormond Street Hospital for Children NHS Foundation Trust
  • Guy's and St Thomas' NHS Foundation Trust
  • King's College Hospital NHS Trust
  • King's College London
  • Manchester University NHS Foundation Trust
  • NHS Lothian
  • Newcastle-upon-Tyne Hospitals NHS Trust
  • North Bristol NHS Trust
  • Northern Care Alliance NHS Foundation Trust
  • Nottingham University Hospitals NHS Trust
  • Oxford University Hospitals NHS Trust
  • University College, London
  • University Hospital Birmingham NHS Foundation Trust
  • University Hospital Southampton NHS Foundation Trust
  • University Hospitals Bristol and Weston NHS Foundation Trust
  • Walton Centre NHS Foundation Trust
Data source: Guy's and St Thomas' NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .